A functional serotonin transporter (SLC6A4) polymorphism modifies the association of smoking and diabetes with asymptomatic carotid atherosclerosis

Birger Wolff; Hans J. Grabe; Henry Völzke; Jan Lüdemann; Christian Schwahn; Harald J. Freyberger; Ulrich John; Martina Lange; Ingolf Cascorbi; Stephan B. Felix

doi:10.1055/s-0037-1616164

Thrombosis and Haemostasis, Table of Contents

Thromb Haemost 2005; 93(01): 180-182
DOI: 10.1055/s-0037-1616164

Letters to the Editor

Schattauer GmbH

A functional serotonin transporter (SLC6A4) polymorphism modifies the association of smoking and diabetes with asymptomatic carotid atherosclerosis

Authors

Birger Wolff^*

¹Klinik für Innere Medizin B, Peter Holtz Research Center of Pharmacology and Experimental Therapeutics, Universität Greifswald, Greifswald, Germany
Hans J. Grabe^*

²Klinik für Psychiatrie und Psychotherapie, Peter Holtz Research Center of Pharmacology and Experimental Therapeutics, Universität Greifswald, Greifswald, Germany
Henry Völzke

³Institut für Epidemiologie und Sozialmedizin, Peter Holtz Research Center of Pharmacology and Experimental Therapeutics, Universität Greifswald, Greifswald, Germany
Jan Lüdemann

³Institut für Epidemiologie und Sozialmedizin, Peter Holtz Research Center of Pharmacology and Experimental Therapeutics, Universität Greifswald, Greifswald, Germany
Christian Schwahn

⁴Klinik für Zahnheilkunde, Peter Holtz Research Center of Pharmacology and Experimental Therapeutics, Universität Greifswald, Greifswald, Germany
Harald J. Freyberger

²Klinik für Psychiatrie und Psychotherapie, Peter Holtz Research Center of Pharmacology and Experimental Therapeutics, Universität Greifswald, Greifswald, Germany
Ulrich John

³Institut für Epidemiologie und Sozialmedizin, Peter Holtz Research Center of Pharmacology and Experimental Therapeutics, Universität Greifswald, Greifswald, Germany
Martina Lange

⁵Institut für Pharmakologie, Peter Holtz Research Center of Pharmacology and Experimental Therapeutics, Universität Greifswald, Greifswald, Germany
Ingolf Cascorbi

⁵Institut für Pharmakologie, Peter Holtz Research Center of Pharmacology and Experimental Therapeutics, Universität Greifswald, Greifswald, Germany
Stephan B. Felix

¹Klinik für Innere Medizin B, Peter Holtz Research Center of Pharmacology and Experimental Therapeutics, Universität Greifswald, Greifswald, Germany

References
1 Lesch KP, Bengel D, Heils A. et al Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 1996; 274: 1527-31.
2 Greenberg BD, Tolliver TJ, Huang SH. et al Genetic variation in the serotonin transporter promoter region affects serotonin uptake in human blood platelets. Am J Med Genet 1999; 88: 83-7.
3 Hanna GL, Himle JA, Curtis GC. et al Serotonin transporter and seasonal variation in blood serotonin in families with obsessive-compulsive disorder. Neuropsychopharmacology 1998; 18: 102-11.
4 Fumeron F, Betoulle D, Nicaud V. et al Serotonin transporter gene polymorphism and myocardial infarction: Etude Cas-Temoins de l'Infarctus du Myocarde (ECTIM). Circulation 2002; 105: 2943-5.
5 Arinami T, Ohtsuki T, Yamakawa-Kobayashi K. et al A synergistic effect of serotonin transporter gene polymorphism and smoking in association with CHD. Thromb Haemost 1999; 81: 853-6.
6 Coto E, Reguero JR, Alvarez V. et al 5-Hydroxytryptamine 5-HT2A receptor and 5-hydroxytryptamine transporter polymorphisms in acute myocardial infarction. Clin Sci 2003; 104: 241-5.
7 Craven TE, Ryu JE, Espeland MA. et al Evaluation of the associations between carotid artery atherosclerosis and coronary artery stenosis. Circulation 1990; 82: 1230-42.
8 Wolff B, Volzke H, Ludemann J. et al Association between high serum ferritin levels and carotid atherosclerosis in the Study of Health in Pomerania (SHIP). Stroke 2004; 35: 435-57.
9 Hioki H, Aoki N, Kawano K. et al Acute effects of cigarette smoking on platelet-dependent thrombin generation. Eur Heart J 2001; 22: 56-61.
10 Haramaki N, Ikeda H, Takajo Y. et al Long-term smoking causes nitroglycerin resistance in platelets by depletion of intraplatelet glutathione. Arterioscler Thromb Vasc Biol 2001; 21: 1852-6.
11 Markovitz JH, Tolbert L, Winders SE. Increased serotonin receptor density and platelet GPIIb/IIIa activation among smokers. Arterioscler Thromb Vasc Biol 1999; 19: 762-6.
12 Li Y, Woo V, Bose R. Platelet hyperactivity and abnormal calcium homeostasis in diabetes mellitus. Am J Physiol Heart Circ Physiol 2001; 280: 1480-9.
13 Pietraszek MH, Takada Y, Takada A. et al Blood serotonergic mechanisms in type 2 (non-insulin-dependent) diabetes mellitus. Thromb Res 1992; 66: 765-74.